Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy

J Clin Oncol. 2024 Aug 10;42(23):2727-2730. doi: 10.1200/JCO.24.01061. Epub 2024 Jun 28.

Authors

Mark Y Jeng¹, Helena A Yu¹

Affiliation

¹ Department of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

PMID: 38941569
DOI: 10.1200/JCO.24.01061

No abstract available

Publication types

Editorial

MeSH terms

Humans
Meningeal Carcinomatosis / drug therapy
Meningeal Carcinomatosis / secondary
Meningeal Neoplasms* / drug therapy
Meningeal Neoplasms* / secondary
Tyrosine Kinase Inhibitors*

Substances

Tyrosine Kinase Inhibitors